Lilly Global Health: Evidence-based approaches to improve outcomes for MDR-TB and NCDs

The McGill Global Health Programs is proud to support this special lecture from the Infectious Diseases and Immunity in Global Health (IDIGH) Program Seminar Series featuring Dr. Evan Lee, VP Global Health at Eli Lilly. Dr. Lee will review the broader context on how the pharma industry is now involved in global health. He will also speak about current partnerships in Multi-drug resistant Tuberculosis and, more recently, work in Non-Communicable diseases.

Learn more here.